Literature DB >> 2359082

Eosinophilic fasciitis after allogeneic bone marrow transplantation.

H M Markusse1, B A Dijkmans, W E Fibbe.   

Abstract

We describe a patient with eosinophilic fasciitis (EF) developing 8 months after an allogeneic bone marrow transplantation for acute myeloblastic leukemia. The patient responded to low dose prednisone. A full thickness skin-muscle-fascia biopsy detected the characteristic fascial changes of EF and distinguished it from other forms of chronic graft-versus-host-disease (GVHD). This distinction may be important since EF after bone marrow transplantation may occur more often and it may respond to treatment with low doses of prednisone whereas chronic GVHD usually requires more extensive immunosuppressive treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2359082

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease.

Authors:  M Horger; A Boss; W Bethge; C Faul; G Fierlbeck; A Bornemann; C D Claussen; W Vogel
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

2.  Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases.

Authors:  Paola L Minciullo; Fortunato Morabito; Rosalba Mandaglio; Pasquale Iacopino; Sebastiano Gangemi
Journal:  Clin Rheumatol       Date:  2005-06-30       Impact factor: 2.980

Review 3.  Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.

Authors:  Cristina Hidalgo Calleja; Daniel Martín Hidalgo; Concepción Román Curto; Lourdes Vázquez López; Estefanía Pérez López; Mónica Cabrero Calvo; Ana África Martín López; María Dolores Caballero Barrigón; Lucía Lopez-Corral
Journal:  Adv Rheumatol       Date:  2022-08-23

Review 4.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.